vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与FIRST FINANCIAL CORP（THFF）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FIRST FINANCIAL CORP的1.1倍（$75.5M vs $70.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 14.1%），FIRST FINANCIAL CORP自由现金流更多（$86.4M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 20.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
第一美国金融公司是一家美国金融服务企业，主营为房地产与抵押贷款行业提供产权保险以及结算服务，深耕相关金融领域，是该细分赛道具备专业能力的服务提供商。
PBYI vs THFF — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$70.5M
营收增速更快
PBYI
高出13.6%
14.1%
自由现金流更多
THFF
多$72.0M
$14.4M
两年增速更快
PBYI
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $70.5M |
| 净利润 | — | $21.5M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 37.4% |
| 净利率 | — | 30.4% |
| 营收同比 | 27.7% | 14.1% |
| 净利润同比 | — | 32.1% |
| 每股收益（稀释后） | $0.26 | $1.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITHFF
| Q4 25 | $75.5M | $70.5M | ||
| Q3 25 | $54.5M | $65.8M | ||
| Q2 25 | $52.4M | $63.1M | ||
| Q1 25 | $46.0M | $62.5M | ||
| Q4 24 | $59.1M | $61.8M | ||
| Q3 24 | $80.5M | $58.4M | ||
| Q2 24 | $47.1M | $49.2M | ||
| Q1 24 | $43.8M | $48.4M |
净利润PBYITHFF
| Q4 25 | — | $21.5M | ||
| Q3 25 | $8.8M | $20.8M | ||
| Q2 25 | $5.9M | $18.6M | ||
| Q1 25 | $3.0M | $18.4M | ||
| Q4 24 | — | $16.2M | ||
| Q3 24 | $20.3M | $8.7M | ||
| Q2 24 | $-4.5M | $11.4M | ||
| Q1 24 | $-4.8M | $10.9M |
毛利率PBYITHFF
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYITHFF
| Q4 25 | 22.7% | 37.4% | ||
| Q3 25 | 17.6% | 39.2% | ||
| Q2 25 | 12.7% | 36.2% | ||
| Q1 25 | 8.7% | 38.1% | ||
| Q4 24 | 22.6% | 32.4% | ||
| Q3 24 | 27.4% | 17.9% | ||
| Q2 24 | -4.6% | 27.6% | ||
| Q1 24 | -5.3% | 27.2% |
净利率PBYITHFF
| Q4 25 | — | 30.4% | ||
| Q3 25 | 16.2% | 31.6% | ||
| Q2 25 | 11.2% | 29.5% | ||
| Q1 25 | 6.5% | 29.5% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 25.2% | 15.0% | ||
| Q2 24 | -9.6% | 23.1% | ||
| Q1 24 | -11.0% | 22.6% |
每股收益（稀释后）PBYITHFF
| Q4 25 | $0.26 | $1.81 | ||
| Q3 25 | $0.17 | $1.75 | ||
| Q2 25 | $0.12 | $1.57 | ||
| Q1 25 | $0.06 | $1.55 | ||
| Q4 24 | $0.40 | $1.37 | ||
| Q3 24 | $0.41 | $0.74 | ||
| Q2 24 | $-0.09 | $0.96 | ||
| Q1 24 | $-0.10 | $0.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $188.2M |
| 股东权益账面价值 | $130.3M | $650.9M |
| 总资产 | $216.3M | $5.8B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.29× |
8季度趋势，按日历期对齐
现金及短期投资PBYITHFF
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYITHFF
| Q4 25 | $22.7M | $188.2M | ||
| Q3 25 | $34.0M | $170.5M | ||
| Q2 25 | $45.3M | $122.7M | ||
| Q1 25 | $56.7M | $124.9M | ||
| Q4 24 | $68.0M | $28.1M | ||
| Q3 24 | $79.3M | $30.5M | ||
| Q2 24 | $90.7M | $108.6M | ||
| Q1 24 | $102.0M | $58.6M |
股东权益PBYITHFF
| Q4 25 | $130.3M | $650.9M | ||
| Q3 25 | $115.3M | $622.2M | ||
| Q2 25 | $104.7M | $587.7M | ||
| Q1 25 | $97.1M | $571.9M | ||
| Q4 24 | $92.1M | $549.0M | ||
| Q3 24 | $71.1M | $566.0M | ||
| Q2 24 | $48.5M | $530.7M | ||
| Q1 24 | $51.0M | $520.8M |
总资产PBYITHFF
| Q4 25 | $216.3M | $5.8B | ||
| Q3 25 | $202.9M | $5.7B | ||
| Q2 25 | $194.9M | $5.6B | ||
| Q1 25 | $196.2M | $5.5B | ||
| Q4 24 | $213.3M | $5.6B | ||
| Q3 24 | $220.7M | $5.5B | ||
| Q2 24 | $205.0M | $4.9B | ||
| Q1 24 | $214.1M | $4.9B |
负债/权益比PBYITHFF
| Q4 25 | 0.17× | 0.29× | ||
| Q3 25 | 0.30× | 0.27× | ||
| Q2 25 | 0.43× | 0.21× | ||
| Q1 25 | 0.58× | 0.22× | ||
| Q4 24 | 0.74× | 0.05× | ||
| Q3 24 | 1.12× | 0.05× | ||
| Q2 24 | 1.87× | 0.20× | ||
| Q1 24 | 2.00× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $90.4M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $86.4M |
| 自由现金流率自由现金流/营收 | 19.1% | 122.5% |
| 资本支出强度资本支出/营收 | 0.0% | 5.6% |
| 现金转化率经营现金流/净利润 | — | 4.21× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $144.3M |
8季度趋势，按日历期对齐
经营现金流PBYITHFF
| Q4 25 | $14.4M | $90.4M | ||
| Q3 25 | $9.7M | $26.9M | ||
| Q2 25 | $14.1M | $12.7M | ||
| Q1 25 | $3.6M | $21.1M | ||
| Q4 24 | $15.6M | $60.4M | ||
| Q3 24 | $11.0M | $23.3M | ||
| Q2 24 | $1.0M | $8.8M | ||
| Q1 24 | $11.2M | $12.4M |
自由现金流PBYITHFF
| Q4 25 | $14.4M | $86.4M | ||
| Q3 25 | $9.7M | $25.8M | ||
| Q2 25 | $14.1M | $11.6M | ||
| Q1 25 | $3.6M | $20.5M | ||
| Q4 24 | $15.6M | $54.3M | ||
| Q3 24 | $11.0M | $19.5M | ||
| Q2 24 | $1.0M | $8.4M | ||
| Q1 24 | — | $11.5M |
自由现金流率PBYITHFF
| Q4 25 | 19.1% | 122.5% | ||
| Q3 25 | 17.7% | 39.2% | ||
| Q2 25 | 26.8% | 18.4% | ||
| Q1 25 | 7.7% | 32.8% | ||
| Q4 24 | 26.4% | 87.8% | ||
| Q3 24 | 13.7% | 33.5% | ||
| Q2 24 | 2.1% | 17.2% | ||
| Q1 24 | — | 23.7% |
资本支出强度PBYITHFF
| Q4 25 | 0.0% | 5.6% | ||
| Q3 25 | 0.0% | 1.7% | ||
| Q2 25 | 0.0% | 1.8% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.0% | 6.5% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.0% | 2.0% |
现金转化率PBYITHFF
| Q4 25 | — | 4.21× | ||
| Q3 25 | 1.10× | 1.29× | ||
| Q2 25 | 2.41× | 0.68× | ||
| Q1 25 | 1.21× | 1.14× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | 0.54× | 2.67× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
